Healthcare provider profile · identity verified

Afsheen Abdul Karim, MD

Family Practice · LANCASTER, PA · NPI 1518173558

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Simvastatin	Simvastatin	410	107
Lisinopril	Lisinopril	409	110
Omeprazole	Omeprazole	406	113
Levothyroxine Sodium	Levothyroxine Sodium	398	98
Amlodipine Besylate	Amlodipine Besylate	369	99
Atorvastatin Calcium	Atorvastatin Calcium	366	114
Albuterol Sulfate Hfa	Albuterol Sulfate	340	102
Rosuvastatin Calcium	Rosuvastatin Calcium	324	87
Montelukast Sodium	Montelukast Sodium	267	93
Metformin Hcl	Metformin Hcl	231	75
Gabapentin	Gabapentin	219	56
Losartan Potassium	Losartan Potassium	177	45
Metoprolol Succinate	Metoprolol Succinate	172	53
Sertraline Hcl	Sertraline Hcl	166	46
Fluticasone Propionate	Fluticasone Propionate	158	62
Furosemide	Furosemide	156	47
Metformin Hcl Er	Metformin Hcl	148	43
Hydrochlorothiazide	Hydrochlorothiazide	142	40
Meloxicam	Meloxicam	141	35
Duloxetine Hcl	Duloxetine Hcl	136	28
Pantoprazole Sodium	Pantoprazole Sodium	130	38
Zolpidem Tartrate	Zolpidem Tartrate	129	20
Azithromycin	Azithromycin	119	84
Alprazolam	Alprazolam	109	18
Quetiapine Fumarate	Quetiapine Fumarate	108	25
Prednisone	Prednisone	105	51
Tizanidine Hcl	Tizanidine Hcl	103	38
Triamcinolone Acetonide	Triamcinolone Acetonide	103	49
Lorazepam	Lorazepam	102	28
Metoprolol Tartrate	Metoprolol Tartrate	102	30
Buspirone Hcl	Buspirone Hcl	100	25
Pravastatin Sodium	Pravastatin Sodium	99	32
Alendronate Sodium	Alendronate Sodium	98	27
Tramadol Hcl	Tramadol Hcl	98	22
Ozempic	Semaglutide	94	17
Valsartan	Valsartan	91	28
Glipizide Er	Glipizide	89	27
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	88	56
Linzess	Linaclotide	87	23
Diclofenac Sodium	Diclofenac Sodium	86	35
Trazodone Hcl	Trazodone Hcl	85	21
Citalopram Hbr	Citalopram Hydrobromide	83	24
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	82	26
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	80	28
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	79	14
Famotidine	Famotidine	76	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	74	32
Allopurinol	Allopurinol	72	18
Glimepiride	Glimepiride	72	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	72	22
Fluconazole	Fluconazole	68	32
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	68	22
Ibuprofen	Ibuprofen	67	20
Oxycodone Hcl	Oxycodone Hcl	67	11
Eliquis	Apixaban	66	16
Potassium Chloride	Potassium Chloride	64	20
Atenolol	Atenolol	63	18
Escitalopram Oxalate	Escitalopram Oxalate	62	18
Trulicity	Dulaglutide	61	20
Mirtazapine	Mirtazapine	58	13
Donepezil Hcl	Donepezil Hcl	57	16
Breo Ellipta	Fluticasone/Vilanterol	56	13
Carvedilol	Carvedilol	56	14
Aripiprazole	Aripiprazole	53	13
Nystatin	Nystatin	53	29
Temazepam	Temazepam	53	suppressed
Januvia	Sitagliptin Phosphate	52	15
Sumatriptan Succinate	Sumatriptan Succinate	52	15
Jardiance	Empagliflozin	51	18
Fenofibrate	Fenofibrate	50	14
Mounjaro	Tirzepatide	50	12
Topiramate	Topiramate	46	11
Meclizine Hcl	Meclizine Hcl	45	15
Hydroxyzine Hcl	Hydroxyzine Hcl	44	18
Synthroid	Levothyroxine Sodium	44	15
Tamsulosin Hcl	Tamsulosin Hcl	44	16
Clonazepam	Clonazepam	43	suppressed
Cephalexin	Cephalexin	42	36
Ondansetron Hcl	Ondansetron Hcl	42	23
Vitamin D2	Ergocalciferol (Vitamin D2)	42	17
Clopidogrel	Clopidogrel Bisulfate	40	13
Pregabalin	Pregabalin	40	suppressed
Bupropion Xl	Bupropion Hcl	39	12
Fluoxetine Hcl	Fluoxetine Hcl	39	suppressed
Glipizide	Glipizide	39	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	39	29
Paroxetine Hcl	Paroxetine Hcl	39	11
Ezetimibe	Ezetimibe	38	13
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	37	suppressed
Tradjenta	Linagliptin	37	suppressed
Doxepin Hcl	Doxepin Hcl	36	suppressed
Spironolactone	Spironolactone	36	13
Oxybutynin Chloride Er	Oxybutynin Chloride	35	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	33	11
Farxiga	Dapagliflozin Propanediol	33	suppressed
Azelastine Hcl	Azelastine Hcl	32	13
Baclofen	Baclofen	32	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	32	20
Fenofibrate	Fenofibrate Nanocrystallized	32	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	31	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	30	suppressed
Naproxen	Naproxen	30	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	30	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	29	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	29	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	28	suppressed
Ibandronate Sodium	Ibandronate Sodium	27	suppressed
Prazosin Hcl	Prazosin Hcl	27	suppressed
Ropinirole Hcl	Ropinirole Hcl	26	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	25	suppressed
Nebivolol Hcl	Nebivolol Hcl	25	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	24	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	24	suppressed
Varenicline Tartrate	Varenicline Tartrate	24	suppressed
Ventolin Hfa	Albuterol Sulfate	24	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Memantine Hcl	Memantine Hcl	23	suppressed
Clindamycin Hcl	Clindamycin Hcl	22	12
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	22	suppressed
Nifedipine Er	Nifedipine	22	suppressed
Amoxicillin	Amoxicillin	21	14
Ciprofloxacin Hcl	Ciprofloxacin Hcl	21	17
Ondansetron Odt	Ondansetron	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Propranolol Hcl Er	Propranolol Hcl	20	suppressed
Bumetanide	Bumetanide	19	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	17
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	18	suppressed
Methylprednisolone	Methylprednisolone	18	15
Novolog Flexpen	Insulin Aspart	18	suppressed
Rizatriptan	Rizatriptan Benzoate	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Benazepril Hcl	Benazepril Hcl	17	suppressed
Finasteride	Finasteride	17	suppressed
Celecoxib	Celecoxib	16	suppressed
Irbesartan	Irbesartan	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Restasis	Cyclosporine	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Klor-Con M20	Potassium Chloride	15	suppressed
Lamotrigine	Lamotrigine	15	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Calcitriol	Calcitriol	14	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Raloxifene Hcl	Raloxifene Hcl	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Carisoprodol	Carisoprodol	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Travoprost	Travoprost	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Ofloxacin	Ofloxacin	12	suppressed
Sulfasalazine	Sulfasalazine	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Trintellix	Vortioxetine Hydrobromide	12	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	11	suppressed
Dexlansoprazole Dr	Dexlansoprazole	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Levalbuterol Tartrate Hfa	Levalbuterol Tartrate	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error